Global Gene Delivery Technologies Market Size 2024, Forecast To 2033
6 Mar, 2024
The gene delivery technologies market size has witnessed rapid growth, surging from $3.57 billion in 2023 to $4.11 billion in 2024, reflecting a compound annual growth rate (CAGR) of 15.2%. The upswing in the historic period is attributed to the enhanced understanding of genetic diseases, advancements in cell therapy, evolution of nanotechnology, and the proliferation of gene therapy trials, alongside an increase in research funding. Forecasts indicate continued rapid expansion, reaching $6.96 billion in 2028, with a CAGR of 14.1%. This growth is fueled by the development of precision medicine, enhancements in regulatory frameworks, the proliferation of gene therapy, and the expansion of non-viral delivery systems. Major trends in the forecast period include application in rare diseases, a rise in clinical trials, targeted drug delivery, expansion of cell therapy, and the development of gene editing tools.
Global Gene Delivery Technologies Market Key Driver
The increasing number of cell and gene therapies is expected to propel the growth of the gene delivery technologies market going forward. Cell and gene therapies refer to medical treatments that aim to cure or alleviate diseases by altering a patient's body's genetic and cellular makeup. The increasing number of cell and gene therapies is mainly driven by advancements in gene editing technologies, playing a critical role in developing and commercializing cell and gene therapies. For instance, in October 2022, according to an article published by Economist Impact, a UK-based corporation empowering businesses, governments, and foundations to catalyze change and enable progress, in mid-2021 around 2,600 clinical trials for CGTs were underway. Companies have conducted over half of it since 2015, and these have increased as per their research demand in multiple fields. Researchers estimate that by 2031, the United States will have 100 approved CGTs. Additionally, between 2022 and 2031, the FDA is expected to approve 8 or 9 CGTs per year on average. Therefore, increasing cell and gene therapies drive the gene delivery technologies market. By 2024, the gene delivery technologies market is anticipated to experience significant growth due to the expanding scope of cell and gene therapy applications.
Get A Free Sample Of The Global Gene Delivery Technologies Market ReportGlobal Gene Delivery Technologies Market Segments
The gene delivery technologies market covered in this report is segmented –
1) By Mode: Biological, Chemical, Physical
2) By Method: Ex Vivo, In Vivo, In Vitro
3) By Application: Gene Therapy, Cell Therapy, Vaccines, Research
By Geography:The regions covered in the gene delivery technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
North America was the largest region in the gene delivery technologies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global gene delivery technologies market report during the forecast period. The regions covered in the gene delivery technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Gene Delivery Technologies Industry Players
Thermo Fisher Scientific Inc., QIAGEN NV, Horizon Discovery Group Co, OriGene Technologies Inc., Oxford Biomedica Solutions LLC, SignaGen Laboratories LLC, Vectalys SAS, Takara Bio Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, Promega Corporation, Hoffmann-La Roche AG, Catalent Inc., Avantor, Pfizer Inc., Becton Dickinson and Company, Novartis AG, Intellia Therapeutics Inc., Editas Medicine Inc., CRISPR Therapeutics AG, Spark Therapeutics Inc., Bluebird Bio Inc., Sarepta Therapeutics Inc., Regenexxbio Inc., Beam Therapeutics Inc., Verve Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Translate Bio Inc., CureVac N.V., Lonza Group AG
Get The Full Global Gene Delivery Technologies Market Report
Gene Delivery Technologies Market Overview
Gene delivery technologies refer to methods that are used to introduce foreign genetic material, such as DNA or RNA, into cells, where the goal of gene delivery is to transfer the genetic material into the target cells. These technologies are commonly used in treating diseases or disorders caused by changed gene-like mutations or an inherited gene.
Gene Delivery Technologies Global Market Report 2023 provides data on the global gene delivery technologies market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The gene delivery technologies market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.